Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6681-6689

  Scognamiglio, Paola ^a   Accapezzato, Daniele ^a   Casciaro, Marco Antonio ^a   Cacciani, Antonella ^a   Artini, Marco ^a   Bruno, Guglielmo ^a   Chircu, Maria Lucia ^a   Sidney, John ^b   Southwood, Scott ^b   Abrignani, Sergio ^c   Sette, Alessandro ^b   Barnaba, Vincenzo ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Epimmune   (United States)

^c CHIRON VACCINES   (Italy)

^d Pasteur Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; EPITOPE; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; ANTIGEN PRESENTATION; ANTIGENS, CD28; ANTIGENS, CD45; CELL LINE; CELL SEPARATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HLA-A2 ANTIGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; OLIGOPEPTIDES; STEM CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033151898     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Choo, Q.-L., G. Kuo, A. J. Weiner, L.R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359.
2. Choo, Q.-L., A. J. Weiner, L. R. Overby, G. Kuo, M. Houghton, and D. W. Bradley. 1990. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 46:423.
3. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q.-L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547.
4. Brettler, D. B., P. M. Mannucci, A. Gringeri, J. E. Rasko, A. D. Forsberg, M. G. Rumi, R. J. Garsia, K. A. Rickard, and M. Colombo. 1992. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood 80:540.
5. Meisel, H., A. Reip, B. Faltus, M. Lu, H. Porst, M. Wiese, M. Roggendorf, and D. H. Kruger. 1995. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 345:1209.
6. Thomas, D. L., D. Vlahov, L. Solomon, S. Cohn, E. Taylor, R. Garfein, and K. E. Nelson. 1995. Correlates of hepatitis C virus infections among injection drug users. Medicine 74:212.
7. Bronowicki, J. P., D. Vetter, G. Uhl, H. Hudziak, A. Uhrlacher, J. M. Vetter, and M. Doffoel. 1997. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J. Infect. Dis. 176:518.
8. Koziel, M. J., D. K. Wong, D. Dudley, M. Houghton, and B. D. Walker. 1997. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J. Infect. Dis. 176:859.
9. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
10. Erickson, A. L., M. Houghton, Q. L. Choo, A. J. Weiner, R. Ralston, E. Muchmore, and C. M. Walker. 1993. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151:4189.
11. Koziel, M. J., Dudley D., J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339.
12. Koziel, M. J., D. Dudley, N. Afdhal, Q. L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522.
13. Koziel, M. J., D. Dudley, N. Afdhal, A. Grakoui, C. M. Rice, Q. L. Choo, M. Houghton, and B. D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:2311.
14. Rehermann, B., Chang K. M., J. G. McHutchison, R. Kokka, M. Houghton, and F. V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432.
15. Wong, D. K., D. D. Dudley, N. H. Afdhal, J. Dienstag, C. M. Rice, L. Wang, M. Houghton, B. D. Walker, and M. J. Koziel. 1998. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160:1479.
16. Sidney, J., H. M. Grey, S. Southwood, E. Celis, P. A. Wentworth, M. F. del Guercio, R. T. Kubo, R. W. Chesnut, and A. Sette. 1996. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45:79.
17. Sidney, J., M. F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H. G. Rammensee, K. Falk, O. Rotzschke, M. Takiguchi, R. T. Kubo, H. M. Grey, and A. Sette. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247.
18. del Guercio, M. F., J. Sidney, G. Hermanson, C. Perez, H. M. Grey, R. T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685.
19. Sidney, J., S. Southwood, M. F. del Guercio, H. M. Grey, R. W. Chesnut, R. T. Kubo, and A. Sette. 1996. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157:3480.
20. Sette, A., J. Sidney, M. F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813.
21. Sette, A., S. Buus, S. Colon, C. Miles, and H. M. Grey. 1989. Structural analysis of peptides capable of binding to more than one la antigen. J. Immunol. 142:35.
22. Wentworth, P. A., A. Sette, E. Celis, J. Sidney, S. Southwood, C. Crimi, S. Stitely, E. Keogh, N. C. Wong, B. Livingston, D. Alazard, A. Vitiello, H. M. Grey, F. V. Chisari, R. W. Chesnut, and J. Fikes. 1996. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int. Immunol. 8:651.
23. Doolan, D. L., S. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, D. M. Gordon, A. Oloo, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97.
24. Bertoni, R., J. Sidney, P. Fowler, R. W. Chesnut, F. V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:503.
25. + memory T cells. J. Exp. Med. 186:859.
26. + T cells using an ELISPOT assay. J. Immunol. Methods 181:45.
27. McCutcheon, M., N. Wehner, A. Wensky, M. Kushner, S. Doan, L. Hsiao, P. Calabresi, T. Ha, T. V. Tran, K. M. Tate. J. Winkelhake, and E. G. Spack. 1997. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods 210:149.
28. Murali, K. K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
29. + T cells during an acute virus infection. Immunity 8:167.
30. Artini, M., C. Natoli, N. Tinari, R. Marinelli, C. Balsano, P. Porcari, D. Angelucci, M. D'Egidio, M. Levrero, and S. Iacobelli. 1996. Elevated serum levels of 90K/MAC-2BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients. J. Hepatol. 25:212.
31. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2. 1 molecules. Cell 74:929.
32. Rebai, N., and B. Malissen. 1983. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22:107.
33. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9.
34. Barnaba, V., A. Franco, A. Albert, C. Balsano, R. Benvenuto, and F. Balsano. 1989. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J. Immunol. 143:2650.
35. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 152:3074.
36. Gagliardi, M. C., P. G. De Petrillo, S. Salemi, L. Boffa, M. G. Longobardi, P. Dellabona, G. Casorati, N. Tanigaki, R. Harris, A. Lanzavecchia, and V. Bamaba 1995. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol. 7:1741.
37. + T cells. J. Exp. Med. 186:1407.
38. Sprent, J. 1997. Immunological memory. Curr. Opin. Immunol. 9:371.
39. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
40. Sarawar, S. R., and P. C. Doherty. 1994. Concurrent production of interleukin-2, interleukin-10, and γ interferon in the regional lymph nodes of mice with influenza pneumonia. J. Virol. 68:3112.
41. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
42. Kagi, D., and H. Hengartner. 1996. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8:472.
43. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, and A. J. McMichael. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103.
44. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395.
45. Ohto, H., S. Terazawa, N. Sasaki, N. Sasaki, K. Hino, C. Ishiwata, M. Kako, N. Ujiie, C. Endo, A. Matsui, K. Okamoto, S. Mishiro, and the Vertical Transmission of Hepatitis C Virus Collaborative Study Group. 1994. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N. Engl. J. Med. 330:744.
46. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H. N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1 J. Infect. Dis. 165:1012.
47. De Maria, M. A., C. Cirillo, and L. Moretta. 1994. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J. Infect. Dis. 170:1296.
48. Mazzoli, S., D. Trabattoni, C. S. Lo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, M. L. Fusi, N. Tofani, M. Biasin, M. L. Villa, F. Mazzotta, and M. Clerici. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1250.
49. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7:448.
50. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
51. Zinkernagel, R. M., M. F. Bachmann, T. M. Kundig, S. Oehen, H. Pirchet, and H. Hengartner. 1996. On immunological memory. Annu. Rev. Immunol. 14:333.
52. Kundig, T. M., M. F. Bachmann, P. S. Ohashi, H. Pircher, H. Hengartner, and R. M. Zinkernagel. 1996. On T cell memory: arguments for antigen dependence. Immunol. Rev. 150:63.
53. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
54. Bachmann, M. P., T. M. Kundig, H. Hengartner, and R. M. Zinkernagel. 1997. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc. Natl. Acad. Sci. USA 94:640.
55. Bretscher, P. A., G. Wei, J. N. Menon, and O. H. Bielefeldt 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539.
56. Clerici, M., E. A. Clark, P. Polacino, I. Axberg, L. Kuller, N. I. Casey, W. R. Morton, G. M. Shearer, and R. E. Benveniste. 1994. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8:1391.
57. Barnaba, V., A. Franco, A. Alberti, R. Benvenuto, and F. Balsano. 1990. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 345:258.
58. Planz, O., P. Seiler, H. Hengartner, and R. M. Zinkernagel. 1996. Specific cytotoxic T cells eliminate B cells producing vims-neutralizing antibodies. Nature 382:726.